AQIA (Aquiva Group) LT-Debt-to-Total-Asset: 0.21 (As of Sep. 2008)


What is Aquiva Group LT-Debt-to-Total-Asset?

Aquiva Group AQIA LT-Debt-to-Total-Asset is 0.21 as of Sep. 2008.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Aquiva Group's long-term debt to total assests ratio for the quarter that ended in Sep. 2008 was 0.21.

Aquiva Group's long-term debt to total assets ratio increased from Sep. 2007 (0.00) to Sep. 2008 (0.21). It may suggest that Aquiva Group is progressively becoming more dependent on debt to grow their business.

Aquiva Group  (OTCPK:AQIA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Aquiva Group LT-Debt-to-Total-Asset Related Terms

Aquiva Group LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Aquiva Group's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aquiva Group LT-Debt-to-Total-Asset Chart

Aquiva Group Annual Data
Trend Mar06 Mar07 Mar08
LT-Debt-to-Total-Asset
0.00 0.00 0.06

Aquiva Group Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.06 0.16 0.21

Aquiva Group LT-Debt-to-Total-Asset Calculation

Aquiva Group's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2008 is calculated as

LT Debt to Total Assets (A: Mar. 2008 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2008 )/Total Assets (A: Mar. 2008 )
=0.5/8.044
=

Aquiva Group's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2008 is calculated as

LT Debt to Total Assets (Q: Sep. 2008 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2008 )/Total Assets (Q: Sep. 2008 )
=1.75/8.166
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.21 mean?
Aquiva Group (AQIA) has a LT-Debt-to-Total-Asset of 0.21 as of Sep. 2008. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Aquiva Group and its competitors.
Is Aquiva Group's LT-Debt-to-Total-Asset too high?
Aquiva Group's current LT-Debt-to-Total-Asset is 0.21.
How does Aquiva Group's LT-Debt-to-Total-Asset compare to LOGQ and MUSS?
Aquiva Group's LT-Debt-to-Total-Asset of 0.21 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Software company?
A good LT-Debt-to-Total-Asset depends on the Software industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Aquiva Group and its competitors. Aquiva Group's current LT-Debt-to-Total-Asset is 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquiva Group stock overvalued right now?
Aquiva Group (AQIA) has a current LT-Debt-to-Total-Asset of 0.21. The current LT-Debt-to-Total-Asset is 0.21. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Aquiva Group (AQIA), the current LT-Debt-to-Total-Asset is 0.21 as of Sep. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aquiva Group Business Description

Address No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
Aquiva Group Inc is focused on commercializing materials science technologies in both existing and emerging markets. It has licensed a novel HiPNATM (Hydrogel with InterPenetrating Network Anchor) technology, branded as AquiFormTM, which is a versatile material with key properties, making it an attractive platform for various applications. These applications include transdermal patches that release active ingredients for skin care, nutraceuticals, and other healthcare and cosmetics markets. The company operates across three segments: Consumer Health, Wellness, & Cosmetics; Medical Device; and Therapeutics & Transdermal Drug-Delivery Systems (TDS). Additionally, it is building on an established partnership network and capabilities in contract development to expand its services to new areas.